The estimated Net Worth of Benjamin Wolin is at least $11.8 Milion dollars as of 1 September 2022. Mr. Wolin owns over 7,529 units of Covetrus stock worth over $4,240,337 and over the last 9 years he sold CVET stock worth over $3,496,332. In addition, he makes $4,065,210 as President, Chief Executive Officer a Director at Covetrus.
Benjamin has made over 33 trades of the Covetrus stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 7,529 units of CVET stock worth $158,034 on 1 September 2022.
The largest trade he's ever made was selling 41,925 units of Covetrus stock on 20 May 2022 worth over $859,463. On average, Benjamin trades about 9,521 units every 33 days since 2015. As of 1 September 2022 he still owns at least 202,017 units of Covetrus stock.
You can see the complete history of Mr. Wolin stock trades at the bottom of the page.
Benjamin Wolin serves as President, Chief Executive Officer, Director of the Company. Mr. Wolin also currently serves as the President and Chief Executive Officer of the Company. Separate from his work for the company, Mr. Wolin currently serves as an advisor to 3L Capital LLC, a growth-stage private equity firm. Prior to his experience as an advisor, Mr. Wolin served as the Chief Executive Officer and Co-founder of Everyday Health, Inc., a communications and marketing platform for consumers, doctors and healthcare companies, and a member of its Board of Directors from 2002 to 2016. Mr. Wolin founded Everyday Health and served as its Chief Executive Officer from inception, through its initial public offering and sale in 2016. Mr. Wolin currently serves as Chairman of the Board of Rockwell Medical, Inc., and as a member of the audit committee and nominating and governance committee. Mr. Wolin also currently serves as a member of the Board of Directors of two private companies, Dance Biopharm, and AdhereTech, Inc. Mr. Wolin received his B.A. in History from Bowdoin College. Mr. Wolin’s extensive experience with digital healthcare, pharmacy, technology, and public company Board governance and his financial and operating expertise led to the conclusion that he should serve as a member of the Covetrus Board.
As the President, Chief Executive Officer a Director of Covetrus, the total compensation of Benjamin Wolin at Covetrus is $4,065,210. There are no executives at Covetrus getting paid more.
Benjamin Wolin is 45, he's been the President, Chief Executive Officer a Director of Covetrus since 2020. There are 23 older and 2 younger executives at Covetrus. The oldest executive at Covetrus, Inc. is Philip Laskawy, 78, who is the Independent Chairman of the Board.
Benjamin's mailing address filed with the SEC is 7, Custom House Street, India Street, Portland, Cumberland County, Maine, 04101, United States.
Over the last 5 years, insiders at Covetrus have traded over $10,243,394 worth of Covetrus stock and bought 11,744 units worth $216,180 . The most active insiders traders include Steven Paladino, Benjamin Wolin a Philip A Laskawy. On average, Covetrus executives and independent directors trade stock every 10 days with the average trade being worth of $268,798. The most recent stock trade was executed by Rebecca Ann Kidd on 1 October 2022, trading 1,232 units of CVET stock currently worth $25,860.
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions that include, inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software systems for veterinary practitioners and animal-health clinics, client communication services, reminders, data backup services, and hardware sales and support services. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal and equine markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine.
Covetrus executives and other stock owners filed with the SEC include: